CORDIS
EU research results

CORDIS

English EN

EUROPEAN NETWORK for CANCER research in CHILDREN and ADOLESCENTS

Objective

ENCCA aims to establish a durable, European Virtual Institute clinical and translational research in childhood and adolescent cancers that will define and implement an integrated research strategy and will facilitate the necessary investigator-driven clinical trials to introduce the new generation of biologically targeted drugs into standard of care for children and adolescents with cancer. This will lead to more efficacious and less toxic therapies that will maximise the quality of life of the increasing number of survivors of cancer at a young age in Europe and allow them to assume their proper place in society. This biologically-driven research agenda will improve training of the clinical investigators and translational scientists of the future to spread excellence, increase capacity to participate in research and monitor outcomes across Europe. Patients and their families will be full partners and will be better informed about the need for and processes of clinical research. They will be in a better situation to care from their long term health risks for children. Drug development will be accelerated in partnership with industry through improved access to young patients with cancer, to academic expertise in care, clinical and biological research. All of this will be achieved with respect for the highest ethical and patient safety standards. ENCCA will bring all stakeholders to the table in a timely and efficacious manner. It will address the needs of all the current multinational clinical trial groups for the benefit of children with cancer. It will provide them with common tools and approaches to solve the bottlenecks in testing new therapeutic strategies for those rare diseases in a vulnerable age group and in running a competitive clinical research agenda. Ongoing efforts to coordinate EU and US clinical research will be reinforced. ENCCA will be led by the most active EU institutes in the field (31), recognised as being at the forefront of excellence.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

ST. ANNA KINDERKREBSFORSCHUNG

Address

Zimmermannplatz 10
1090 Wien

Austria

Activity type

Research Organisations

EU Contribution

€ 1 643 402,80

Administrative Contact

Ruth Ladenstein (Prof.)

Participants (33)

Sort alphabetically

Sort by EU Contribution

Expand all

SIOP EUROPE ASBL

Belgium

EU Contribution

€ 550 080,40

UNIVERSITY COLLEGE LONDON

United Kingdom

EU Contribution

€ 739 313,60

CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL

Germany

EU Contribution

€ 695 664,50

INSTITUT GUSTAVE ROUSSY

France

EU Contribution

€ 830 002

UNIVERSITA CATTOLICA DEL SACRO CUORE

Italy

EU Contribution

€ 449 460

UNIVERSITAETSKLINIKUM ESSEN

Germany

EU Contribution

€ 146 970,36

UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA

Italy

EU Contribution

€ 331 808,10

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

Netherlands

EU Contribution

€ 266 994

FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA

Spain

EU Contribution

€ 263 128

GDANSKI UNIWERSYTET MEDYCZNY

Poland

EU Contribution

€ 148 915,60

THE UNIVERSITY OF BIRMINGHAM

United Kingdom

EU Contribution

€ 327 319,60

THE LEEDS TEACHING HOSPITALS NATIONAL HEALTH SERVICE TRUST

United Kingdom

EU Contribution

€ 344 450,71

ISTITUTO GIANNINA GASLINI

Italy

EU Contribution

€ 438 014,40

INSTITUT CURIE

France

EU Contribution

€ 638 373,21

IDRYMA TECHNOLOGIAS KAI EREVNAS

Greece

EU Contribution

€ 339 621

AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH

Austria

EU Contribution

€ 504 788,95

CINECA CONSORZIO INTERUNIVERSITARIO

Italy

EU Contribution

€ 273 791,25

ESQH VIENNA OFFICE - EUROPAISCHE GESELLSCHAFT FUR QUALITAT IM GESUNDHEITSWESEN - WIENER BURO VEREIN

Austria

EU Contribution

€ 111 960

ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM

Netherlands

EU Contribution

€ 519 307

CENTRE DE LUTTE CONTRE LE CANCER LEON BERARD

France

EU Contribution

€ 130 152

CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER

France

EU Contribution

€ 257 763,29

ACADEMISCH ZIEKENHUIS LEIDEN

Netherlands

EU Contribution

€ 154 383

KAROLINSKA INSTITUTET

Sweden

EU Contribution

€ 27 860,80

UNIVERSITEIT GENT

Belgium

EU Contribution

€ 54 480,40

CHARITE - UNIVERSITAETSMEDIZIN BERLIN

Germany

EU Contribution

€ 370 372,14

ASSISTANCE PUBLIQUE HOPITAUX DE PARIS

France

EU Contribution

€ 69 304,80

LANDESHAUPTSTADT STUTTGART

Germany

EU Contribution

€ 210 981,50

European CanCer Organisation

Belgium

EU Contribution

€ 320 723,20

OSTERREICHISCHE KINDER-KREBS-HILFE-VERBAND DER OSTERREICHISCHEN KINDER-KREBS-HILFE-ORGANISATIONEN VEREIN

Austria

EU Contribution

€ 283 214,99

UNIVERSITA DEGLI STUDI DI PADOVA

Italy

EU Contribution

€ 193 311,30

WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER

Germany

EU Contribution

€ 70 000

UNIVERSITY OF SOUTHAMPTON

United Kingdom

EU Contribution

€ 225 389,50

UNIVERSITY OF LEEDS

United Kingdom

EU Contribution

€ 66 656,50

Project information

Grant agreement ID: 261474

Status

Closed project

  • Start date

    1 January 2011

  • End date

    31 December 2015

Funded under:

FP7-HEALTH

  • Overall budget:

    € 14 221 575,67

  • EU contribution

    € 11 997 958,90

Coordinated by:

ST. ANNA KINDERKREBSFORSCHUNG

Austria